Triglav Skladi, D.O.O. Sarepta Therapeutics, Inc. Transaction History
Triglav Skladi, D.O.O.
- $1.2 Trillion
- Q1 2025
A detailed history of Triglav Skladi, D.O.O. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Triglav Skladi, D.O.O. holds 11,000 shares of SRPT stock, worth $220,879. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,000
Previous 11,000
-0.0%
Holding current value
$220,879
Previous $1.34 Billion
47.51%
% of portfolio
0.06%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$207 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$182 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$181 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$81.7 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$67.6 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.76B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...